Trevi Therapeutics Inc (TRVI) Wheel Strategy

Running a TRVI wheel strategy lets you generate consistent premium income on Trevi Therapeutics Inc while setting your own entry and exit prices on the underlying. Trevi Therapeutics Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own TRVI, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best TRVI wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on TRVI, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable TRVI wheel from a losing one.

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the TRVI wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your TRVI wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.